therapy
The risk of AMI might be remarkably       reduced by using low-dose UK in combination with antithrombin therapy before       thrombolytic therapy.
The risk of AMI might be remarkably       reduced by using low-dose UK in combination with  @OBJECT$  @PREDICAT$  @SUBJECT$  before       thrombolytic therapy.